• Marksans Pharma reported a 20.21% increase in net sales and a 22.22% decrease in net profit for the September 2023 quarter.
• EBITDA also decreased by 2.88% compared to the same quarter last year.
• The company's EPS has decreased from Rs. 1.00 to Rs. 0.......read more